Cargando…
Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility?
The effects of many chemotherapeutic drugs on ribosome biogenesis have been underestimated for a long time. Indeed, many drugs currently used for cancer treatment – and which are known to either damage DNA or hinder DNA synthesis – have been shown to exert their toxic action mainly by inhibiting rRN...
Autores principales: | Brighenti, Elisa, Treré, Davide, Derenzini, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770724/ https://www.ncbi.nlm.nih.gov/pubmed/26415219 |
Ejemplares similares
-
The Ribosome Biogenesis—Cancer Connection
por: Penzo, Marianna, et al.
Publicado: (2019) -
Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why
por: Derenzini, Enrico, et al.
Publicado: (2018) -
Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate
por: Brighenti, Elisa, et al.
Publicado: (2016) -
Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer
por: Brighenti, E, et al.
Publicado: (2014) -
The emerging role of RNA polymerase I transcription machinery in human malignancy: a clinical perspective
por: Montanaro, Lorenzo, et al.
Publicado: (2013)